{'fraction_non_alphanumeric': 0.029906542056074768, 'fraction_numerical': 0.009345794392523364, 'mean_word_length': 6.052631578947368, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Influence of thyroxine on serum soluble interleukin‐2 receptor alpha levels in thyroid disorders

Background:  Activation of cell‐mediated immunity by soluble interleukin‐2 receptor alpha (sIL‐2Rα) release is well documented. The aim of this study was to measure serum concentrations of sIL‐2Rα in patients with autoimmune and non‐autoimmune thyroid disorders in different stages of thyroid function, before and after administration of l‐thyroxine (l‐T4) and its discontinuation as well as before and during methimazole administration.